WEAVER GREGORY L Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$307,227.72
Insider Sells Quantity
3
Insider Sells Sum
$671,841.58

Insider Activity of WEAVER GREGORY L

According to the SEC Form 4 filings, WEAVER GREGORY L, being in a position of

  1. Chief Financial Officer at Altimmune, Inc.,
    оver the last 12 months, has bought 15000 shares for $49,199, and sold 0 shares,
    over all time since 2025-03-13, has bought 25000 shares for $101,195, and sold 0 shares.

Biography of WEAVER GREGORY L

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $49,1992100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-04-01PurchaseAltimmune, Inc.
ALT
Chief Financial Officer
10,000
0.0114%
$3.15$31,499-5.13%
2026-03-06PurchaseAltimmune, Inc.
ALT
Chief Financial Officer
5,000
0.0057%
$3.54$17,700-15.25%
2025-03-13PurchaseAltimmune, Inc.
ALT
Chief Financial Officer
10,000
0.013%
$5.20$51,996-18.08%
2023-11-15SaleAtossa Therapeutics, Inc.
ATOS
Former EVP, CFO, & Director
50,000
0.0395%
$0.65$32,500+103.08%
2023-06-20PurchaseAtossa Therapeutics, Inc.
ATOS
EVP & CFO
50,000
0.0401%
$0.97$48,500-1.18%
2021-07-02SaleAtossa Therapeutics, Inc.
ATOS
director
107,497
0.0883%
$5.58$599,833-69.09%
2018-03-23PurchaseEloxx Pharmaceuticals, Inc.
ELOX
Chief Financial Officer
4,500
0.0156%
$8.56$38,520+51.11%
2013-11-21PurchaseAtossa Therapeutics, Inc.
ATOS
director
20,000
0.1359%
$2.58$51,570-30.41%
2013-03-19SaleImunon, Inc.
IMNN
CFO
37,272
0.3232%
$1.06$39,508-5.66%
2011-12-06PurchaseImunon, Inc.
IMNN
CFO
5,000
0.0879%
$2.15$10,750+5.42%
2011-05-26PurchaseImunon, Inc.
IMNN
director
8,636
0.1957%
$2.77$23,922-10.65%
2010-09-16PurchaseImunon, Inc.
IMNN
director
5,000
0.1268%
$3.10$15,500-6.11%
2007-02-23PurchaseImunon, Inc.
IMNN
director
10,000
0.2863%
$3.50$35,000+55.62%
Total: 13
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.